{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:30:16Z","timestamp":1793478616510,"version":"4.5.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10528-026-11415-0","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:03:02Z","timestamp":1781769782000},"page":"7835-7853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exercise-Driven NRF2 Activation as a Systemic Neuroprotective Strategy: Integrating Redox Biology, Muscle\u2013Brain Crosstalk, and Therapeutic Targeting in Neurodegeneration"],"prefix":"10.1007","volume":"64","author":[{"given":"Pichao","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"4","key":"11415_CR1","doi-asserted-by":"publisher","first-page":"964","DOI":"10.14336\/AD.2021.0511","volume":"12","author":"A Anandhan","year":"2021","unstructured":"Anandhan A et al (2021) NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human \u03b1-Synuclein Overexpressing Mice. Aging disease 12(4):964\u2013982","journal-title":"Aging disease"},{"issue":"1","key":"11415_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11064-024-04319-1","volume":"50","author":"M Aqeel","year":"2025","unstructured":"Aqeel M et al (2025) Glycyrrhizic Acid Mitigates Haloperidol-Induced Neurotoxicity in SHSY-5Y Cells and Rats Via Activation of PI3k\/Akt\/Nrf2 Pathways. Neurochem Res 50(1):75","journal-title":"Neurochem Res"},{"key":"11415_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00099-20","author":"L Baird","year":"2020","unstructured":"Baird L, Yamamoto M (2020) The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. Mol Cell Biol. https:\/\/doi.org\/10.1128\/MCB.00099-20","journal-title":"Mol Cell Biol"},{"key":"11415_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","volume":"85","author":"L Baird","year":"2011","unstructured":"Baird L, Dinkova-Kostova AT (2011) The cytoprotective role of the Keap1\u2013Nrf2 pathway. Arch Toxicol 85:241\u2013272","journal-title":"Arch Toxicol"},{"key":"11415_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2016.06.027","volume":"100","author":"PS Baxter","year":"2016","unstructured":"Baxter PS, Hardingham GE (2016) Adaptive regulation of the brain\u2019s antioxidant defences by neurons and astrocytes. Free Radic Biol Med 100:147\u2013152","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"11415_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza I et al (2018) Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res 1865(5):721\u2013733","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"11415_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/aian.AIAN_169_18","volume":"21","author":"KS Bhalsing","year":"2018","unstructured":"Bhalsing KS, Abbas MM, Tan LCS (2018) Role of Physical Activity in Parkinson\u2019s Disease. Ann Indian Acad Neurol 21(4):242\u2013249","journal-title":"Ann Indian Acad Neurol"},{"key":"11415_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010008","author":"SM Boas","year":"2021","unstructured":"Boas SM, Joyce KL, Cowell RM (2021) The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11010008","journal-title":"Antioxidants"},{"issue":"1","key":"11415_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-021-00479-8","volume":"16","author":"S Bono","year":"2021","unstructured":"Bono S, Feligioni M, Corbo M (2021) Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Mol Neurodegeneration 16(1):71","journal-title":"Mol Neurodegeneration"},{"issue":"12","key":"11415_CR10","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/mp.2016.211","volume":"22","author":"E Bouvier","year":"2017","unstructured":"Bouvier E et al (2017) Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression. Mol Psychiatry 22(12):1795","journal-title":"Mol Psychiatry"},{"issue":"24","key":"11415_CR11","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1093\/hmg\/ddx361","volume":"26","author":"C Branca","year":"2017","unstructured":"Branca C et al (2017) Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 26(24):4823\u20134835","journal-title":"Hum Mol Genet"},{"key":"11415_CR12","doi-asserted-by":"publisher","first-page":"175909141989978","DOI":"10.1177\/1759091419899782","volume":"12","author":"MS Brandes","year":"2020","unstructured":"Brandes MS, Gray NE (2020) NRF2 as a Therapeutic Target in Neurodegenerative Diseases. ASN Neuro 12:1759091419899782","journal-title":"ASN Neuro"},{"issue":"3","key":"11415_CR13","doi-asserted-by":"publisher","first-page":"e0120254","DOI":"10.1371\/journal.pone.0120254","volume":"10","author":"MS Brennan","year":"2015","unstructured":"Brennan MS et al (2015) Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS ONE 10(3):e0120254","journal-title":"PLoS ONE"},{"issue":"12","key":"11415_CR14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1007\/s11064-010-0307-z","volume":"35","author":"V Calabrese","year":"2010","unstructured":"Calabrese V et al (2010) Cellular Stress Responses, Mitostress and Carnitine Insufficiencies as Critical Determinants in Aging and Neurodegenerative Disorders: Role of Hormesis and Vitagenes. Neurochem Res 35(12):1880\u20131915","journal-title":"Neurochem Res"},{"key":"11415_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11020195","author":"SJ Cha","year":"2022","unstructured":"Cha SJ, Kim K (2022) Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11020195","journal-title":"Antioxidants"},{"key":"11415_CR16","first-page":"31","volume-title":"Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer\u2019s Disease","author":"J Chand","year":"2025","unstructured":"Chand J, Subramanian G (2025) Neurodegenerative Disorders: Types, Classification, and Basic Concepts. Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer\u2019s Disease. Springer, pp 31\u201340"},{"issue":"6","key":"11415_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/antiox13060649","volume":"13","author":"K-H Chang","year":"2024","unstructured":"Chang K-H, Chen C-M (2024) The role of NRF2 in trinucleotide repeat expansion disorders. Antioxidants 13(6):649","journal-title":"Antioxidants"},{"key":"11415_CR18","doi-asserted-by":"publisher","first-page":"1381467","DOI":"10.3389\/fonc.2024.1381467","volume":"14","author":"F Chen","year":"2024","unstructured":"Chen F et al (2024) Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer. Front Oncol 14:1381467","journal-title":"Front Oncol"},{"issue":"12","key":"11415_CR19","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1177\/0271678X20960033","volume":"40","author":"AK Chokkalla","year":"2020","unstructured":"Chokkalla AK, Mehta SL, Vemuganti R (2020) Epitranscriptomic regulation by m(6)A RNA methylation in brain development and diseases. J Cereb Blood Flow Metab 40(12):2331\u20132349","journal-title":"J Cereb Blood Flow Metab"},{"key":"11415_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-014-0064-6","volume":"12","author":"HM Crook-McMahon","year":"2014","unstructured":"Crook-McMahon HM et al (2014) Genome-wide screening identifies new genes required for stress-induced phase 2 detoxification gene expression in animals. BMC Biol 12:1\u201317","journal-title":"BMC Biol"},{"issue":"4","key":"11415_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado A et al (2019) Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov 18(4):295\u2013317","journal-title":"Nat Rev Drug Discov"},{"key":"11415_CR22","doi-asserted-by":"publisher","first-page":"122261","DOI":"10.1016\/j.lfs.2023.122261","volume":"335","author":"X Cui","year":"2023","unstructured":"Cui X et al (2023) Omaveloxolone ameliorates cognitive dysfunction in APP\/PS1 mice by stabilizing the STAT3 pathway. Life Sci 335:122261","journal-title":"Life Sci"},{"key":"11415_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107913","author":"Y Dai","year":"2025","unstructured":"Dai Y et al (2025) Exercise and the Organ-Brain Axis: Regulation of Neurological Disorders by Emerging Exerkines. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2025.107913","journal-title":"Pharmacol Res"},{"issue":"3","key":"11415_CR24","first-page":"1419","volume":"18","author":"S Darabi","year":"2019","unstructured":"Darabi S et al (2019) Trehalose Neuroprotective Effects on the Substantia Nigra Dopaminergic Cells by Activating Autophagy and Non-canonical Nrf2 Pathways. Iran J Pharm Res 18(3):1419\u20131428","journal-title":"Iran J Pharm Res"},{"issue":"5","key":"11415_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","volume":"9","author":"A De la Rosa","year":"2020","unstructured":"De la Rosa A et al (2020) Physical exercise in the prevention and treatment of Alzheimer\u2019s disease. J Sport Health Sci 9(5):394\u2013404","journal-title":"J Sport Health Sci"},{"key":"11415_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030549","author":"LM De Plano","year":"2023","unstructured":"De Plano LM et al (2023) The Role of the Transcription Factor Nrf2 in Alzheimer\u2019s Disease: Therapeutic Opportunities. Biomolecules. https:\/\/doi.org\/10.3390\/biom13030549","journal-title":"Biomolecules"},{"issue":"4","key":"11415_CR27","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/alz.12946","volume":"19","author":"DP Devanand","year":"2023","unstructured":"Devanand DP, Masurkar AV, Wisniewski T (2023) Vigorous, regular physical exercise may slow disease progression in Alzheimer\u2019s disease. Alzheimers Dement 19(4):1592\u20131597","journal-title":"Alzheimers Dement"},{"key":"11415_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/genes10090720","author":"CM Di Liegro","year":"2019","unstructured":"Di Liegro CM et al (2019) Physical Activity and Brain Health. Genes (Basel). https:\/\/doi.org\/10.3390\/genes10090720","journal-title":"Genes (Basel)"},{"key":"11415_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.redox.2016.10.003","volume":"10","author":"AJ Done","year":"2016","unstructured":"Done AJ, Traustad\u00f3ttir T (2016) Nrf2 mediates redox adaptations to exercise. Redox Biol 10:191\u2013199","journal-title":"Redox Biol"},{"key":"11415_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2016.04.024","volume":"96","author":"AJ Done","year":"2016","unstructured":"Done AJ et al (2016) Exercise-induced Nrf2-signaling is impaired in aging. Free Radic Biol Med 96:130\u2013138","journal-title":"Free Radic Biol Med"},{"issue":"13","key":"11415_CR31","first-page":"2369","volume":"39","author":"L El Hayek","year":"2019","unstructured":"El Hayek L et al (2019) Lactate Mediates the Effects of Exercise on Learning and Memory through SIRT1-Dependent Activation of Hippocampal Brain-Derived Neurotrophic Factor (BDNF). J Neurosci 39(13):2369\u20132382","journal-title":"J Neurosci"},{"issue":"1","key":"11415_CR32","doi-asserted-by":"publisher","first-page":"e16172","DOI":"10.1371\/journal.pone.0016172","volume":"6","author":"G Ellrichmann","year":"2011","unstructured":"Ellrichmann G et al (2011) Efficacy of Fumaric Acid Esters in the R6\/2 and YAC128 Models of Huntington\u2019s Disease. PLoS ONE 6(1):e16172","journal-title":"PLoS ONE"},{"issue":"11","key":"11415_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140963","volume":"10","author":"JW Fahey","year":"2015","unstructured":"Fahey JW et al (2015) Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase. PLoS One 10(11):e0140963","journal-title":"PLoS One"},{"key":"11415_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu17081353","author":"JW Fahey","year":"2025","unstructured":"Fahey JW et al (2025) Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders. Nutrients. https:\/\/doi.org\/10.3390\/nu17081353","journal-title":"Nutrients"},{"issue":"23","key":"11415_CR35","doi-asserted-by":"publisher","first-page":"21208","DOI":"10.1021\/acs.jmedchem.4c02019","volume":"67","author":"I Fejes","year":"2024","unstructured":"Fejes I et al (2024) Covalent Inhibitors of KEAP1 with Exquisite Selectivity. J Med Chem 67(23):21208\u201321222","journal-title":"J Med Chem"},{"key":"11415_CR36","first-page":"103","volume":"9","author":"SD Ghanekar","year":"2019","unstructured":"Ghanekar SD et al (2019) Orphan Drugs In Development For The Treatment Of Friedreich\u2019s Ataxia: Focus On Omaveloxolone. Degener Neurol Neuromuscul Dis 9:103\u2013107","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"11415_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.inat.2023.101947","volume":"36","author":"M Ghorbani","year":"2024","unstructured":"Ghorbani M et al (2024) Trehalose: A promising new treatment for traumatic brain injury? A systematic review of animal evidence. Interdiscip Neurosurg 36:101947","journal-title":"Interdiscip Neurosurg"},{"key":"11415_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fgene.2019.00435","volume":"10","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Shaforostova EA, Popov VN (2019) Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1\u03b1 Signaling Pathways. Front Genet 10:435","journal-title":"Front Genet"},{"issue":"7","key":"11415_CR39","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/antiox12071371","volume":"12","author":"M Hammad","year":"2023","unstructured":"Hammad M et al (2023) Roles of oxidative stress and Nrf2 signaling in pathogenic and non-pathogenic cells: a possible general mechanism of resistance to therapy. Antioxidants 12(7):1371","journal-title":"Antioxidants"},{"issue":"4","key":"11415_CR40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ibra.12183","volume":"10","author":"M Hashmi","year":"2024","unstructured":"Hashmi M et al (2024) The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies. Ibrain 10(4):395\u2013426","journal-title":"Ibrain"},{"key":"11415_CR41","first-page":"4","volume":"4","author":"CM Hine","year":"2012","unstructured":"Hine CM, Mitchell JR (2012) NRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction. J Clin Exp Pathol S 4:4","journal-title":"J Clin Exp Pathol"},{"key":"11415_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2017.06.027","volume":"336","author":"Y Hou","year":"2018","unstructured":"Hou Y et al (2018) Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1\/TXNIP complex in cerebral ischemia reperfusion injury. Behav Brain Res 336:32\u201339","journal-title":"Behav Brain Res"},{"issue":"4","key":"11415_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/tx100389r","volume":"24","author":"C Hu","year":"2011","unstructured":"Hu C et al (2011) Modification of keap1 cysteine residues by sulforaphane. Chem Res Toxicol 24(4):515\u201321","journal-title":"Chem Res Toxicol"},{"key":"11415_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2019.03.010","volume":"853","author":"C Huang","year":"2019","unstructured":"Huang C et al (2019) Effects of sulforaphane in the central nervous system. Eur J Pharmacol 853:153\u2013168","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"11415_CR45","doi-asserted-by":"publisher","first-page":"e11838","DOI":"10.1371\/journal.pone.0011838","volume":"5","author":"NG Innamorato","year":"2010","unstructured":"Innamorato NG et al (2010) Different susceptibility to the Parkinson\u2019s toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS ONE 5(7):e11838","journal-title":"PLoS ONE"},{"issue":"12","key":"11415_CR46","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/cmi.2017.114","volume":"14","author":"JJ Jhang","year":"2017","unstructured":"Jhang JJ, Yen GC (2017) The role of Nrf2 in NLRP3 inflammasome activation. Cell Mol Immunol 14(12):1011\u20131012","journal-title":"Cell Mol Immunol"},{"issue":"Pt B","key":"11415_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","volume":"88","author":"T Jiang","year":"2015","unstructured":"Jiang T et al (2015) p62 links autophagy and Nrf2 signaling. Free Radic Biol Med 88(Pt B):199\u2013204","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"11415_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-025-02145-7","volume":"10","author":"Q Jiang","year":"2025","unstructured":"Jiang Q et al (2025) Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances. Signal Transduct Target Therapy 10(1):76","journal-title":"Signal Transduct Target Therapy"},{"key":"11415_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9070617","author":"TC Kang","year":"2020","unstructured":"Kang TC (2020) Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2) and Mitochondrial Dynamics\/Mitophagy in Neurological Diseases. Antioxidants. https:\/\/doi.org\/10.3390\/antiox9070617","journal-title":"Antioxidants"},{"key":"11415_CR50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4018\/979-8-3693-5464-3.ch015","volume-title":"Advancing Medical Research Through Neuroscience","author":"N Khare","year":"2025","unstructured":"Khare N, Khare P, Priyadarshi S (2025) Investigating Neurodegenerative Diseases From Alzheimer\u2019s to Parkinson\u2019s. Advancing Medical Research Through Neuroscience. IGI Global Scientific Publishing, pp 399\u2013436"},{"key":"11415_CR51","doi-asserted-by":"publisher","first-page":"102830","DOI":"10.1016\/j.redox.2023.102830","volume":"65","author":"DC Levings","year":"2023","unstructured":"Levings DC et al (2023) Limited expression of Nrf2 in neurons across the central nervous system. Redox Biol 65:102830","journal-title":"Redox Biol"},{"issue":"1","key":"11415_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neurom.2023.11.006","volume":"28","author":"A Lewis","year":"2025","unstructured":"Lewis A et al (2025) The Effects of Transcranial Direct Current Stimulation and Exercise on Salivary S100B Protein Indicated Blood-Brain Barrier Permeability: A Pilot Study. Neuromodulation 28(1):76\u201385","journal-title":"Neuromodulation"},{"issue":"9","key":"11415_CR53","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/D0FO02736G","volume":"12","author":"J Li","year":"2021","unstructured":"Li J et al (2021) Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct 12(9):3898\u20133918","journal-title":"Food Funct"},{"key":"11415_CR54","doi-asserted-by":"publisher","first-page":"1462145","DOI":"10.3389\/fmed.2025.1462145","volume":"12","author":"C Li","year":"2025","unstructured":"Li C et al (2025a) Ferroptosis in NAFLD: insights and the therapeutic potential of exercise. Front Med (Lausanne) 12:1462145","journal-title":"Front Med (Lausanne)"},{"key":"11415_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081913","author":"L Li","year":"2025","unstructured":"Li L et al (2025b) Epigenetic Mechanisms Governing Nrf2 Expression and Its Role in Ferroptosis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13081913","journal-title":"Biomedicines"},{"issue":"1","key":"11415_CR56","first-page":"432626","volume":"2014","author":"A LoGerfo","year":"2014","unstructured":"LoGerfo A et al (2014) Lack of association between nuclear factor erythroid-derived 2\u2010like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients. Oxidative Med Cell Longev 2014(1):432626","journal-title":"Oxidative Med Cell Longev"},{"issue":"2","key":"11415_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/antiox14020121","volume":"14","author":"R L\u00f3pez-Hern\u00e1ndez","year":"2025","unstructured":"L\u00f3pez-Hern\u00e1ndez R et al (2025) Inflammasomes in alzheimer\u2019s progression: Nrf2 as a preventive target. Antioxid (Basel) 14(2):121","journal-title":"Antioxid (Basel)"},{"issue":"4","key":"11415_CR58","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/cimb45040217","volume":"45","author":"L L\u00f3pez-Pingarr\u00f3n","year":"2023","unstructured":"L\u00f3pez-Pingarr\u00f3n L et al (2023) Role of oxidative stress on the etiology and pathophysiology of amyotrophic lateral sclerosis (ALS) and its relation with the enteric nervous system. Curr Issues Mol Biol 45(4):3315\u20133332","journal-title":"Curr Issues Mol Biol"},{"key":"11415_CR59","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.2147\/JIR.S478683","volume":"17","author":"R Lu","year":"2024","unstructured":"Lu R et al (2024) Nrf2 Deficiency Exacerbates Parkinson\u2019s Disease by Aggravating NLRP3 Inflammasome Activation in MPTP-Induced Mouse Models and LPS-Induced BV2 Cells. J Inflamm Res 17:6277\u20136295","journal-title":"J Inflamm Res"},{"issue":"2","key":"11415_CR60","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","volume":"89","author":"DR Lynch","year":"2021","unstructured":"Lynch DR et al (2021) Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol 89(2):212\u2013225","journal-title":"Ann Neurol"},{"issue":"1","key":"11415_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12974-019-1403-x","volume":"16","author":"MA Ma\u0142kiewicz","year":"2019","unstructured":"Ma\u0142kiewicz MA et al (2019) Blood-brain barrier permeability and physical exercise. J Neuroinflammation 16(1):15","journal-title":"J Neuroinflammation"},{"key":"11415_CR62","doi-asserted-by":"publisher","first-page":"1437939","DOI":"10.3389\/fphar.2024.1437939","volume":"15","author":"C Mayer","year":"2024","unstructured":"Mayer C et al (2024) Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications. Front Pharmacol 15:1437939","journal-title":"Front Pharmacol"},{"key":"11415_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13050573","author":"Q Meng","year":"2024","unstructured":"Meng Q, Su CH (2024) The Impact of Physical Exercise on Oxidative and Nitrosative Stress: Balancing the Benefits and Risks. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox13050573","journal-title":"Antioxidants (Basel)"},{"issue":"18","key":"11415_CR64","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1113\/JP271957","volume":"594","author":"TL Merry","year":"2016","unstructured":"Merry TL, Ristow M (2016) Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) mediates exercise-induced mitochondrial biogenesis and the anti-oxidant response in mice. J Physiol 594(18):5195\u20135207","journal-title":"J Physiol"},{"issue":"11","key":"11415_CR65","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","volume":"46","author":"E Minj","year":"2021","unstructured":"Minj E, Upadhayay S, Mehan S (2021a) Nrf2\/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS. Neurochem Res 46(11):2867\u20132884","journal-title":"Neurochem Res"},{"issue":"8","key":"11415_CR66","first-page":"630","volume":"21","author":"E Minj","year":"2021","unstructured":"Minj E, Yadav RK, Mehan S (2021b) Targeting abnormal Nrf2\/HO-1 signaling in amyotrophic lateral sclerosis: Current Insights on drug targets and influences on neurological disorders. Curr Mol Med 21(8):630\u2013644","journal-title":"Curr Mol Med"},{"key":"11415_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14050554","author":"A Minuti","year":"2025","unstructured":"Minuti A et al (2025) Role and Functions of Irisin: A Perspective on Recent Developments and Neurodegenerative Diseases. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox14050554","journal-title":"Antioxidants (Basel)"},{"key":"11415_CR68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.redox.2017.09.007","volume":"15","author":"Y Mizunoe","year":"2018","unstructured":"Mizunoe Y et al (2018) Trehalose protects against oxidative stress by regulating the Keap1-Nrf2 and autophagy pathways. Redox Biol 15:115\u2013124","journal-title":"Redox Biol"},{"key":"11415_CR69","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.freeradbiomed.2020.10.022","volume":"162","author":"D Moretti","year":"2021","unstructured":"Moretti D et al (2021) NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington\u2019s disease mouse model. Free Radic Biol Med 162:243\u2013254","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"11415_CR70","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2011.03.027","volume":"51","author":"A Neymotin","year":"2011","unstructured":"Neymotin A et al (2011) Neuroprotective effect of Nrf2\/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 51(1):88\u201396","journal-title":"Free Radic Biol Med"},{"key":"11415_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080296","author":"S Padmanabhan","year":"2019","unstructured":"Padmanabhan S et al (2019) The Michael J. Fox Foundation for Parkinson\u2019s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin. Biomolecules. https:\/\/doi.org\/10.3390\/biom9080296","journal-title":"Biomolecules"},{"key":"11415_CR72","doi-asserted-by":"publisher","first-page":"1243869","DOI":"10.3389\/fnagi.2023.1243869","volume":"15","author":"HA Pahlavani","year":"2023","unstructured":"Pahlavani HA (2023) Exercise therapy to prevent and treat Alzheimer\u2019s disease. Front Aging Neurosci 15:1243869","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"11415_CR73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12935-024-03430-1","volume":"24","author":"R Panahizadeh","year":"2024","unstructured":"Panahizadeh R et al (2024) The interplay between microRNAs and Nrf2 signaling in human cancers. Cancer Cell Int 24(1):234","journal-title":"Cancer Cell Int"},{"key":"11415_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111649","author":"JA Parga","year":"2021","unstructured":"Parga JA et al (2021) NRF2 Activation and Downstream Effects: Focus on Parkinson\u2019s Disease and Brain Angiotensin. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10111649","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"11415_CR75","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/j.2040-4603.2013.tb00522.x","volume":"3","author":"BK Pedersen","year":"2013","unstructured":"Pedersen BK (2013) Muscle as a secretory organ. Compr Physiol 3(3):1337\u20131362","journal-title":"Compr Physiol"},{"issue":"8","key":"11415_CR76","first-page":"e90188","volume":"17","author":"H Qasim","year":"2025","unstructured":"Qasim H et al (2025) Epigenetic Dysregulation in Neurodegenerative Disease: Implications for Neuropathology and Therapy. Cureus 17(8):e90188","journal-title":"Cureus"},{"issue":"23","key":"11415_CR77","doi-asserted-by":"publisher","first-page":"E4676","DOI":"10.1073\/pnas.1614943114","volume":"114","author":"L Quinti","year":"2017","unstructured":"Quinti L et al (2017) KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington\u2019s disease patients. Proc Natl Acad Sci 114(23):E4676\u2013E4685","journal-title":"Proc Natl Acad Sci"},{"key":"11415_CR78","doi-asserted-by":"publisher","first-page":"3050971","DOI":"10.1155\/2020\/3050971","volume":"2020","author":"P Ren","year":"2020","unstructured":"Ren P et al (2020) Nrf2 Ablation Promotes Alzheimer\u2019s Disease-Like Pathology in APP\/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress. Oxid Med Cell Longev 2020:3050971","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"11415_CR79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD (2018) NRF2 and the hallmarks of cancer. Cancer Cell 34(1):21\u201343","journal-title":"Cancer Cell"},{"issue":"8","key":"11415_CR80","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1073\/pnas.1314421111","volume":"111","author":"B Rotblat","year":"2014","unstructured":"Rotblat B et al (2014) HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response. Proc Natl Acad Sci 111(8):3032\u20133037","journal-title":"Proc Natl Acad Sci"},{"key":"11415_CR81","doi-asserted-by":"publisher","first-page":"122393","DOI":"10.1016\/j.lfs.2023.122393","volume":"339","author":"NS Sadier","year":"2024","unstructured":"Sadier NS et al (2024) Irisin: An unveiled bridge between physical exercise and a healthy brain. Life Sci 339:122393","journal-title":"Life Sci"},{"issue":"7","key":"11415_CR82","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","volume":"16","author":"Safety","year":"2017","unstructured":"Safety (2017) efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16(7):505\u2013512and","journal-title":"Lancet Neurol"},{"issue":"6","key":"11415_CR83","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1474-4422(25)00173-5","volume":"24","author":"Safety","year":"2025","unstructured":"Safety (2025) efficacy of trehalose in amyotrophic lateral sclerosis (HEALEY ALS Platform Trial): an adaptive, phase 2\/3, double-blind, randomised, placebo-controlled trial. Lancet Neurol 24(6):500\u2013511and","journal-title":"Lancet Neurol"},{"key":"11415_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313082","author":"A S\u00e1nchez-Sanz","year":"2024","unstructured":"S\u00e1nchez-Sanz A et al (2024) Neuroprotective and Anti-Inflammatory Effects of Dimethyl Fumarate, Monomethyl Fumarate, and Cannabidiol in Neurons and Microglia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252313082","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11415_CR85","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/exnr.1997.6752","volume":"150","author":"HM Schipper","year":"1998","unstructured":"Schipper HM, Liberman A, Stopa EG (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson\u2019s disease. Exp Neurol 150(1):60\u201368","journal-title":"Exp Neurol"},{"key":"11415_CR86","doi-asserted-by":"publisher","first-page":"103906","DOI":"10.1016\/j.redox.2025.103906","volume":"88","author":"MR Schnell","year":"2025","unstructured":"Schnell MR et al (2025) KEAP1 C151 active site catalysis drives electrophilic signaling to upregulate cytoprotective enzyme expression. Redox Biol 88:103906","journal-title":"Redox Biol"},{"issue":"4","key":"11415_CR87","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/neurosci5040032","volume":"5","author":"B Sevriev","year":"2024","unstructured":"Sevriev B et al (2024) Trehalose: neuroprotective effects and mechanisms-an updated review. NeuroSci 5(4):429\u2013444","journal-title":"NeuroSci"},{"issue":"2","key":"11415_CR88","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10072-024-07802-3","volume":"46","author":"V Sharma","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG (2025) Mechanistic insights on the role of Nrf-2 signalling in Huntington\u2019s disease. Neurol Sci 46(2):593\u2013604","journal-title":"Neurol Sci"},{"key":"11415_CR89","doi-asserted-by":"publisher","first-page":"1217730","DOI":"10.3389\/fendo.2023.1217730","volume":"14","author":"GA Sidiropoulou","year":"2023","unstructured":"Sidiropoulou GA, Metaxas A, Kourti M (2023) Natural antioxidants that act against Alzheimer\u2019s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action. Front Endocrinol (Lausanne) 14:1217730","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11415_CR90","doi-asserted-by":"publisher","first-page":"100190","DOI":"10.1016\/j.prmcm.2022.100190","volume":"5","author":"S Singh","year":"2022","unstructured":"Singh S et al (2022) Ferulic acid ameliorates neurodegeneration via the Nrf2\/ARE signalling pathway: A Review. Pharmacol Res - Mod Chin Med 5:100190","journal-title":"Pharmacol Res - Mod Chin Med"},{"key":"11415_CR91","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.15092","author":"SF Sleiman","year":"2016","unstructured":"Sleiman SF et al (2016) Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body \u03b2-hydroxybutyrate. Elife. https:\/\/doi.org\/10.7554\/eLife.15092","journal-title":"Elife"},{"issue":"4","key":"11415_CR92","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s43440-022-00390-z","volume":"74","author":"D Soni","year":"2022","unstructured":"Soni D, Kumar P (2022) GSK-3\u03b2-mediated regulation of Nrf2\/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders. Pharmacol Rep 74(4):557\u2013569","journal-title":"Pharmacol Rep"},{"key":"11415_CR93","doi-asserted-by":"publisher","first-page":"177523","DOI":"10.1016\/j.ejphar.2025.177523","volume":"998","author":"D Soni","year":"2025","unstructured":"Soni D et al (2025) Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against rotenone model of Parkinson\u2019s disease via modulation of GSK-3\u03b2\/ Nrf2\/HO-1 signaling. Eur J Pharmacol 998:177523","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"11415_CR94","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.1007\/s12035-024-04023-9","volume":"61","author":"Z Tang","year":"2024","unstructured":"Tang Z et al (2024) NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer\u2019s disease. Mol Neurobiol 61(10):7517\u20137533","journal-title":"Mol Neurobiol"},{"issue":"3","key":"11415_CR95","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/ijms26031098","volume":"26","author":"H Tkaczenko","year":"2025","unstructured":"Tkaczenko H, Kurhaluk N (2025a) Antioxidant-Rich Functional Foods and Exercise: Unlocking Metabolic Health Through Nrf2 and Related Pathways. Int J Mol Sci 26(3):1098","journal-title":"Int J Mol Sci"},{"key":"11415_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031098","author":"H Tkaczenko","year":"2025","unstructured":"Tkaczenko H, Kurhaluk N (2025b) Antioxidant-Rich Functional Foods and Exercise: Unlocking Metabolic Health Through Nrf2 and Related Pathways. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26031098","journal-title":"Int J Mol Sci"},{"key":"11415_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315272","author":"P Tucci","year":"2022","unstructured":"Tucci P et al (2022) Nrf2 Pathway in Huntington\u2019s Disease (HD): What Is Its Role? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232315272","journal-title":"Int J Mol Sci"},{"key":"11415_CR98","doi-asserted-by":"publisher","first-page":"116285","DOI":"10.1016\/j.intimp.2026.116285","volume":"173","author":"S Upadhayay","year":"2026","unstructured":"Upadhayay S (2026a) Unrevealing role of TLRs\/NLRP receptors in halting Alzheimer\u2019s neuroinflammation: Current progress and existing therapies. Int Immunopharmacol 173:116285","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"11415_CR99","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s12035-026-05772-5","volume":"63","author":"S Upadhayay","year":"2026","unstructured":"Upadhayay S (2026b) Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches. Mol Neurobiol 63(1):516","journal-title":"Mol Neurobiol"},{"issue":"11","key":"11415_CR100","doi-asserted-by":"publisher","first-page":"14367","DOI":"10.1007\/s12035-025-04962-x","volume":"62","author":"S Upadhayay","year":"2025","unstructured":"Upadhayay S et al (2025) Role of Fibroblast Growth Factors in Neurological Disorders: Insight into Therapeutic Approaches and Molecular Mechanisms. Mol Neurobiol 62(11):14367\u201314386","journal-title":"Mol Neurobiol"},{"issue":"6","key":"11415_CR101","doi-asserted-by":"publisher","first-page":"e00467","DOI":"10.1128\/MCB.00467-19","volume":"40","author":"A Uruno","year":"2020","unstructured":"Uruno A et al (2020) Nrf2 Suppresses Oxidative Stress and Inflammation in App Knock-In Alzheimer\u2019s Disease Model Mice. Mol Cell Biol 40(6):e00467\u2013e00419","journal-title":"Mol Cell Biol"},{"issue":"7","key":"11415_CR102","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/cells14070499","volume":"14","author":"S Wang","year":"2025","unstructured":"Wang S et al (2025) Recent Advances in Aging and Immunosenescence: Mechanisms and Therapeutic Strategies. Cells 14(7):499","journal-title":"Cells"},{"issue":"3","key":"11415_CR103","doi-asserted-by":"publisher","first-page":"105456","DOI":"10.1016\/j.jamda.2024.105456","volume":"26","author":"AA Wanigatunga","year":"2025","unstructured":"Wanigatunga AA et al (2025) Moderate-to-Vigorous Physical Activity at any Dose Reduces All-Cause Dementia Risk Regardless of Frailty Status. J Am Med Dir Assoc 26(3):105456","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"11415_CR104","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans 43(4):621\u2013626","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"11415_CR105","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","volume":"18","author":"CD Wrann","year":"2013","unstructured":"Wrann CD et al (2013) Exercise induces hippocampal BDNF through a PGC-1\u03b1\/FNDC5 pathway. Cell Metab 18(5):649\u2013659","journal-title":"Cell Metab"},{"issue":"1","key":"11415_CR106","doi-asserted-by":"publisher","first-page":"12518","DOI":"10.1038\/s41598-025-97101-4","volume":"15","author":"Y Xie","year":"2025","unstructured":"Xie Y et al (2025) Effects of exercise on different antioxidant enzymes and related indicators: a systematic review and meta-analysis of randomized controlled trials. Sci Rep 15(1):12518","journal-title":"Sci Rep"},{"issue":"5","key":"11415_CR107","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/pin.12261","volume":"65","author":"H Yamazaki","year":"2015","unstructured":"Yamazaki H et al (2015) Role of the Keap1\/Nrf2 pathway in neurodegenerative diseases. Pathol Int 65(5):210\u2013219","journal-title":"Pathol Int"},{"key":"11415_CR108","doi-asserted-by":"publisher","first-page":"919233","DOI":"10.3389\/fphar.2022.919233","volume":"13","author":"XX Yang","year":"2022","unstructured":"Yang XX, Yang R, Zhang F (2022) Role of Nrf2 in Parkinson\u2019s Disease: Toward New Perspectives. Front Pharmacol 13:919233","journal-title":"Front Pharmacol"},{"issue":"8","key":"11415_CR109","doi-asserted-by":"publisher","first-page":"2400081","DOI":"10.1002\/smsc.202400081","volume":"4","author":"Z Ye","year":"2024","unstructured":"Ye Z et al (2024) Autocatalytic, Brain Tumor-Targeting Delivery of Bardoxolone Methyl Self-Assembled Nanoparticles for Glioblastoma Treatment. Small Sci 4(8):2400081","journal-title":"Small Sci"},{"key":"11415_CR110","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13632","author":"S Yoo","year":"2025","unstructured":"Yoo S et al (2025) Bardoxolone methyl inhibits ferroptosis through the Keap1\u2011Nrf2 pathway in renal tubular epithelial cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2025.13632","journal-title":"Mol Med Rep"},{"issue":"26","key":"11415_CR111","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","volume":"369","author":"Dd Zeeuw","year":"2013","unstructured":"Zeeuw Dd et al (2013) Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease. N Engl J Med 369(26):2492\u20132503","journal-title":"N Engl J Med"},{"key":"11415_CR112","doi-asserted-by":"publisher","first-page":"1189470","DOI":"10.3389\/fnins.2023.1189470","volume":"17","author":"W Zhou","year":"2023","unstructured":"Zhou W, Xu R (2023) Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis. Front NeuroSci 17:1189470","journal-title":"Front NeuroSci"},{"key":"11415_CR113","doi-asserted-by":"publisher","first-page":"p9275056","DOI":"10.1155\/2022\/9275056","volume":"2022","author":"Y Zhuang","year":"2022","unstructured":"Zhuang Y et al (2022) Regulation of Mitochondrial Homeostasis and Nrf2 in Kidney Disease: Timing Is Critical. Oxid Med Cell Longev 2022:p9275056","journal-title":"Oxid Med Cell Longev"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11415-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11415-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11415-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:02:28Z","timestamp":1793476948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11415-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11415"],"URL":"https:\/\/doi.org\/10.1007\/s10528-026-11415-0","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}